U.S. Mortgage Finance Stock News

Nomad Foods Limited has released its second-quarter and half-year 2026 results, reporting sales of €723.7 million and €1.44 billion respectively, with lower net income and earnings per share than the same periods a year earlier. The simultaneous decline in both sales and profitability across the quarter and first half of 2026 highlights pressure on Nomad Foods’ operational performance and cost management. Next, we will examine how this softer revenue and earnings performance shapes Nomad...

Why Pelagos Insurance Capital Stock Is Back on Investors’ Radar Pelagos Insurance Capital (PLGO) drew fresh attention after reporting second quarter and first half 2026 results that showed higher revenue, a swing to net profit and continued execution on its share repurchase program. See our latest analysis for Pelagos Insurance Capital. Pelagos Insurance Capital’s earnings rebound and ongoing buybacks have come alongside a 24.05% year to date share price return and a 41.39% total shareholder...

Victory Capital Holdings stock update Victory Capital Holdings (VCTR) drew fresh attention after its recent share price move, with the stock closing at $115.63. Investors are weighing this level against the company’s latest financial profile and recent return history. See our latest analysis for Victory Capital Holdings. The recent move to a US$115.63 share price comes after a strong run, with an 18.96% 1 month share price return and an 80.39% year to date share price return, alongside a 5...

Marex Group Limited recently reported half-year 2026 results showing net income of US$268 million and significantly higher earnings per share versus a year earlier, while also affirming a quarterly dividend of US$0.16 per share payable on September 9, 2026. Alongside stronger profitability, Marex’s decision to maintain its regular cash dividend sends a clear signal about management’s confidence in the company’s financial position and cash-generation capacity. We’ll now examine how Marex’s...

TransDigm Group stock performance snapshot TransDigm Group (TDG) has drawn investor attention after a mixed share price pattern. The stock is up about 1.7% today, yet it is down over the past week, month, and past 3 months. Year to date, TransDigm Group has declined about 11.6%, with the 1 year total return down roughly 8.9%. Longer term holders have seen higher total returns over 3 and 5 years, based on the data provided. The company last closed at US$1,200.35, giving TransDigm Group an...

In August 2026, Spyre Therapeutics announced SPY772, a new preclinical combination program pairing its long-acting anti-TL1A antibody SPY072 with the novel long-acting anti-IL-17A/F antibody SPY007, and reported the start of SKYLIGHT, a randomized, placebo-controlled Phase 2 proof-of-concept trial in approximately 150 adults with moderate-to-severe Hidradenitis Suppurativa receiving background bimekizumab therapy, with topline data planned for late 2027 or early 2028. This dual-inhibition...

Hyatt Hotels Corporation and RJR Investments & Holdings Inc. recently added Atlantic Suites Hotel in Georgetown, Guyana to the Hyatt portfolio as its first affiliated property in the country, with plans for an approximately US$50 million expansion that will convert it into Hyatt Regency Georgetown Guyana by 2028. This move extends Hyatt’s reach into an emerging Latin America and Caribbean market while deepening the World of Hyatt ecosystem through future loyalty integration and a planned...

Celcuity (CELC) reported second quarter 2026 results that showed a wider net loss, an update that can influence how investors evaluate the stock’s risk profile and long term development plans. See our latest analysis for Celcuity. Celcuity’s latest earnings report, which showed a larger net loss, arrived as the stock posted a 1 month share price return of 13.21% but a 3 month share price decline of 32.34%. The 1 year total shareholder return of 78.42% highlights how longer term momentum has...

In August 2026, QIAGEN announced that the U.S. FDA had cleared its QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx bloodstream infection panel to receive FDA clearance, expanding the platform’s U.S. coverage to four infectious disease areas and delivering one-hour pathogen and resistance marker results from positive blood cultures. This clearance not only broadens QIAGEN’s infectious disease testing menu on a single integrated platform, but also positions the company to address the...

Credit Acceptance (CACC) has drawn investor attention after completing a US$600 million asset backed non recourse secured financing and naming former Amazon executive Jeetu Mirchandani as Chief Technology Officer earlier this month. See our latest analysis for Credit Acceptance. These financing and leadership moves have come alongside a steady build in momentum for Credit Acceptance, with a 32.41% year to date share price return and a 1 year total shareholder return of 18.67% pointing to...

In the past quarter, Reliance reported strong Q2 2026 results, with adjusted earnings per share rising very large on the back of higher shipments, firmer pricing, and contributions from a U.S. border wall project, while management highlighted healthy demand across non-residential construction, aerospace, automotive, and semiconductor markets. An interesting angle is how the border wall project and improved gross profit per ton show Reliance monetising complex, project-based work alongside...

McGrath RentCorp (MGRC) is back in focus for investors after recent share price swings, with the stock last closing at $116.65. The move is prompting closer attention to its rental-focused business model. See our latest analysis for McGrath RentCorp. Recent trading in McGrath RentCorp has been choppy, with a 7 day share price return of down 4.6% and a 30 day share price return of down 2.6%. However, the year to date share price return of 10.85% and a 5 year total shareholder return of 82.79%...

Candel Therapeutics (CADL) is back in focus after reporting second quarter 2026 results that showed a net loss of US$38.91 million. This compared with net income for the first half of 2025. See our latest analysis for Candel Therapeutics. The earnings release has come alongside strong momentum in Candel Therapeutics' stock, with a 1 month share price return of 37.34% and a year to date share price return of 141.36%. The 3 year total shareholder return is very large at around 9x, suggesting...

Recent performance puts Eastman Chemical in focus Eastman Chemical (EMN) has moved onto investor watchlists after a recent share price run that left the stock up about 9% over the past month and roughly 15% year to date. See our latest analysis for Eastman Chemical. The recent 30 day share price return of 8.64% has helped Eastman Chemical regain some momentum after a flat 90 day move, even though the 5 year total shareholder return of 22.54% below zero shows a weaker longer term picture. If...

Earlier this week, Hyperliquid Strategies drew fresh attention after Donald Trump said CFTC Chair Mike Selig is working on a compliant legal route for the Hyperliquid exchange to operate in the U.S., spotlighting potential regulatory clarity for the platform. This shift toward a possible U.S.-compliant framework has sharpened the focus on how much of Hyperliquid Strategies’ appeal rests on regulatory momentum rather than established financial fundamentals. We’ll now examine how the prospect...

Brinker International (EAT) is in focus after reporting fourth quarter and full year results on August 12, 2026, along with higher fiscal 2027 revenue guidance and a larger share repurchase authorization. See our latest analysis for Brinker International. The stronger fourth quarter and full year earnings on August 12, the higher fiscal 2027 revenue guidance and the expanded buyback authorization have arrived alongside powerful momentum, with Brinker International’s 30 day share price return...

In August 2026, Teradyne, Inc. entered into a five-year senior secured revolving credit facility of US$1.00 billion with PNC Bank and other lenders, providing flexible funding for working capital and general corporate purposes without initially drawing on the line. A key feature of this agreement is that collateral, guarantees, and several restrictive covenants can be lifted if Teradyne maintains investment grade credit ratings from at least two major agencies, potentially giving the...

In August 2026, HighPeak Energy, Inc. reported past second-quarter results showing revenue of US$272.42 million and net income of US$82.28 million, with diluted earnings per share from continuing operations rising to US$0.59 compared with US$0.19 a year earlier. However, for the first half of 2026 the company recorded a net loss of US$45.17 million despite essentially flat year-on-year revenue, highlighting the contrast between a strong second quarter and weaker earlier performance. Next,...

Dole plc recently reported past second-quarter 2026 results, with sales of US$2,499.41 million and net income of US$25.98 million, while also recognizing relatively small impairment and asset write-down charges. Alongside these results, the Board reaffirmed its capital return approach by declaring a US$0.085 per-share cash dividend for the second quarter of 2026, matching the first-quarter payout and underscoring an ongoing cash distribution to shareholders. We will now examine how the...

In August 2026, Birkenstock Holding plc reported higher third-quarter sales year on year and raised its fiscal 2026 revenue growth guidance to 15%, targeting reported revenue at the upper end of EUR 2,300 million to EUR 2,350 million. Alongside this upgraded outlook, the company combined a US$1.00 billion follow-on equity offering with a planned US$500 million share repurchase, signaling a reshaping of its capital structure and balance between growth funding and share count reduction. We’ll...

Concentra Group Holdings Parent (CON) stock is in focus after the company announced that occupational medicine leader Jill Rosenthal will return as chief medical officer, succeeding longtime CMO Dr. John Anderson. See our latest analysis for Concentra Group Holdings Parent. Set against this leadership change, Concentra Group Holdings Parent’s recent momentum has been strong, with an 80.32% year to date share price return and a 49.48% total shareholder return over the past year, while shorter...

In August 2026, Absci Corporation reported positive interim Phase 1 data from its HEADLINETM trial of ABS-201 for pattern hair loss, indicating a favorable safety profile and an estimated half-life of at least 65 days, while also reaffirming plans to advance the program into endometriosis and a Phase 2 trial in 2026. These early results suggest ABS-201 could offer infrequent dosing and a differentiated, non-sex-steroid approach in two large, under-served indications, alongside emerging...

Why Middleby’s latest earnings are getting attention Middleby (MIDD) has drawn fresh attention after reporting second quarter and six month results that showed higher sales alongside sharply lower net income, paired with new guidance following the Food Processing spin off. The company reported second quarter sales of US$875.55 million compared with US$796.80 million a year earlier. Net income for the quarter was US$54.81 million compared with US$105.96 million in the prior year period. See...

In August 2026, NVIDIA Corporation announced memorandums of understanding with KKR & Co. Inc. and five other major financial institutions to create independent compute financing platforms, aiming to mobilize over US$500 billion of third-party capital for AI infrastructure across its ecosystem, subject to final agreements. This move positions KKR as an important capital partner in AI infrastructure financing, aligning its private markets expertise with rising demand for large-scale compute...